Cervical adenocarcinoma has been the subject of sustained clinical investigation across multiple research sites.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID	Title	Status	Phase
NCT00217633	Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer	COMPLETED	PHASE2
NCT00416455	Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer	COMPLETED	PHASE1/PHASE2
NCT02466971	Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers	ACTIVE_NOT_RECRUITING	PHASE3
NCT00803062	Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	COMPLETED	PHASE3
NCT00897442	Collecting Tumor Samples From Patients With Gynecological Tumors	COMPLETED	—
NCT00262821	Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer	TERMINATED	PHASE3
NCT03738228	Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer	COMPLETED	PHASE1
NCT01281852	Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	COMPLETED	PHASE1
NCT00104910	Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer	COMPLETED	PHASE1
NCT01711515	Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer	COMPLETED	PHASE1

Related Pages

All Cervical adenocarcinoma trials All trials in Augusta, United States